Curebase, a platform for decentralized clinical trials, is partnering with AppliedVR to run five trials to test the effectiveness of virtual reality for treating chronic pain.
The companies said the one-year partnership will focus on studying a self-administered, at-home VR therapy program. Curebase will manage patient recruitment, consent, and engagement, and collect patient-reported outcomes data.
“Virtual reality holds tremendous potential to both improve and lower the cost of how we treat chronic pain while also reducing America’s dependence on pharmacological interventions,” AppliedVR president and cofounder Josh Sackman said in a statement.
“Demonstrating that requires effective clinical trials, and Curebase’s technology gives us a user-friendly, end-to-end solution that is highly workflow-oriented and specialized for digital therapeutic study designs.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The COVID-19 pandemic has pushed the use of decentralized clinical trials to continue studies while limiting in-person interactions.
AppliedVR has conducted other studies on its tools. The company’s EaseVRx landed FDA Breakthrough Device designation for its tech to reduce fibromyalgia and chronic lower back pain, and in March swept up $29 million in Series A funding.
Source: Mobihealthnews
